NR-46419金黄色葡萄球菌,AIS080003(细菌)
产品图片
货号/SKU
NR-46419
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质,其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类:美国、2
产品描述信息
NR-46419??Staphylococcus aureus, AIS 080003(Bacteria)|Staphylococcus aureus|AIS 080003|-60°C or colder|J PatelAcknowledgment for publications should read "The following reagent was provided by the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) for distribution by BEI Resources, NIAID, NIH: Staphylococcus aureus, Strain AIS 080003, NR-46419."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Staphylococcus aureus (S. aureus), strain AIS 080003 (also referred to as VRSA-9 and VRS9) was isolated in 2007 in Michigan, USA from a left plantar foot wound of a 54-year-old female who recently received a 4-week course of vancomycin and levofloxacin to treat osteomyelitis of the left metatarsals.
S. aureus, strain AIS 080003 is a vancomycin-resistant S. aureus strain. S. aureus, strain AIS 080003 was deposited as positive for mec and vanA; negative for vanB, vanC1, vanC2, vanD, vanE, PVL and arginine catabolic mobile element (ACME); pulsed-field type USA100; spa repeats TJMBMDMGMK; Ridom spa type t002. S. aureus, strain AIS 080003 is a USA100 isolate. USA100 isolates have the same MLST profile (ST 5), SCCmec (subtype II) and spa motif (MDMGMK) and are usually resistant to erythromycin and spectinomycin as well as being multiresistant to other commonly used therapeutic agents. USA100 is the most prevalent U.S health care-associated pulse-field type and is endemic in many U.S. hospitals. S. aureus, strain AIS080003 is partially dependent on vancomycin for growth due to a mutation in D-alanyl:D-alanine ligase (Ddl), an enzyme involved in biosynthesis of peptidoglycans. The presence of the vanA operon compensates for the Ddl mutation by providing alternative peptidoglycans for cell wall synthesis; however, some have found that this change in the type of peptidoglycans produced renders it susceptible to oxacillin. The complete genome sequence of S. aureus, strain AIS 080003 is available (GenBank: AHBS00000000).
Each vial contains approximately 0.5 mL of bacterial culture in Brain Heart Infusion broth supplemented with 6 ?g/mL vancomycin and 10% glycerol.
Staphylococcus aureus (S. aureus), strain AIS 080003 (also referred to as VRSA-9 and VRS9) was isolated in 2007 in Michigan, USA from a left plantar foot wound of a 54-year-old female who recently received a 4-week course of vancomycin and levofloxacin to treat osteomyelitis of the left metatarsals.
S. aureus, strain AIS 080003 is a vancomycin-resistant S. aureus strain. S. aureus, strain AIS 080003 was deposited as positive for mec and vanA; negative for vanB, vanC1, vanC2, vanD, vanE, PVL and arginine catabolic mobile element (ACME); pulsed-field type USA100; spa repeats TJMBMDMGMK; Ridom spa type t002. S. aureus, strain AIS 080003 is a USA100 isolate. USA100 isolates have the same MLST profile (ST 5), SCCmec (subtype II) and spa motif (MDMGMK) and are usually resistant to erythromycin and spectinomycin as well as being multiresistant to other commonly used therapeutic agents. USA100 is the most prevalent U.S health care-associated pulse-field type and is endemic in many U.S. hospitals. S. aureus, strain AIS080003 is partially dependent on vancomycin for growth due to a mutation in D-alanyl:D-alanine ligase (Ddl), an enzyme involved in biosynthesis of peptidoglycans. The presence of the vanA operon compensates for the Ddl mutation by providing alternative peptidoglycans for cell wall synthesis; however, some have found that this change in the type of peptidoglycans produced renders it susceptible to oxacillin. The complete genome sequence of S. aureus, strain AIS 080003 is available (GenBank: AHBS00000000).
Each vial contains approximately 0.5 mL of bacterial culture in Brain Heart Infusion broth supplemented with 6 ?g/mL vancomycin and 10% glycerol.
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.此限制的订单将在发货前发送到NIAID以批准. 金黄色葡萄球菌(金黄色葡萄球菌),应变AIS 080003(也称为VRSA-9和VRS9)于2007年在密歇根州分离出来,来自一名54岁女性的左跖脚伤口,最近收到了4周的万古霉素和左氧氟沙星治疗左侧跖骨的骨髓炎. s.金黄色葡萄球菌,菌株AIS 080003是一种抗万古霉素的.金黄色葡萄球菌菌株. s.金黄色葡萄球菌,将菌株AIS 080003沉积为阳性的 mec 和 vana ; Vanb , Vanc1, Vanc2 , vand , vane ,pv1和精氨酸分解代谢移动元素(ACME);脉冲场型USA100; spa 重复tjmbmdmgmk; ridom spa 型T002. s.金黄色葡萄球菌,应变AIS 080003是USA100隔离. USA100分离株具有相同的MLST谱(ST 5),SCC MEC (亚型II)和 SPA 图案(MDMGMK),通常耐红霉素和北霉素以及存在对其他常用的治疗剂多敏感. USA100是最普遍的美国医疗保健相关的脉搏场类型,在许多美国医院的地方是流行的. s. AIS080003菌株AIS080003部分依赖于由于D-丙氨酸:D-丙氨酸酶(DDL)中的突变,其中肽聚糖的生物合成酶的突变而依赖于增长.通过提供用于细胞壁合成的替代肽聚糖来补偿DDL突变的 vana 的存在;然而,有些人发现这种肽聚糖类型的这种变化产生的蛋白质易患牛奶蛋白. s的完整基因组序列. AIS ,应变AIS 080003可用(GenBank: ahbs00000000 ). >每个小瓶含有大约0.5ml的脑心输注肉汤中的细菌培养,其补充有6μg/ ml万古霉素和10%甘油.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立,旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中,可以监控科学界对这些材料的访问和使用,并确保试剂的质量控制。
除了为传染病界提供材料外,BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势,包括安全存储、社区访问和分发;同时保护存款人的知识产权。只要有需要,BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月, ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料,包括由其他政府支持的研究项目存放的材料,将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中,涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2025-01-02
2022-04-01
2022-04-01
2022-04-01
2022-04-01
2024-01-21
2025-01-18
2022-04-01
2022-04-01
2021-12-21
2022-08-11
2022-04-01
2024-05-19
2022-04-01
2021-10-31